» Articles » PMID: 34778917

Biological Augments for Acetabular Chondral Defects in Hip Arthroscopy-A Scoping Review of the Current Clinical Evidence

Overview
Date 2021 Nov 15
PMID 34778917
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: A wide array of joint-preserving surgical techniques exists in the management of acetabular chondral defects (ACDs). The purpose of this review is to summarize the clinical outcomes of the recent biologics used to treat ACDs during hip arthroscopy.

Recent Findings: Increasing evidence is available for different biological solutions used in the hip. Studies have shown promising outcomes with minimal complications when using biologics as augmentation to microfracture (MF), including different scaffolds or stem cells, or to enhance autologous chondrocyte implantation (ACI). However, data so far is scarce, and more trials and longer follow-ups are needed to better delineate the appropriate indications and benefits for each technique. Presently, the level of evidence is low, but in general, biologics appear safe and trend toward beneficial compared to standard surgical techniques. Augmented MF is recommended for small to medium ACDs, and matrix-assisted ACI or three-dimensional ACI is recommended for medium to large defects.

Citing Articles

Current understanding of articular cartilage lesions in femoroacetabular impingement syndrome.

Li Z, Yu J, An P, Zhang W, Tian K J Orthop Surg Res. 2024; 19(1):886.

PMID: 39734214 PMC: 11684245. DOI: 10.1186/s13018-024-05322-6.

References
1.
Oladeji L, Cook J, Stannard J, Crist B . Large fresh osteochondral allografts for the hip: growing the evidence. Hip Int. 2017; 28(3):284-290. DOI: 10.5301/hipint.5000568. View

2.
Schallmo M, Marquez-Lara A, Luo T, Rosas S, Stubbs A . Arthroscopic Treatment of Hip Chondral Defect With Microfracture and Platelet-Rich Plasma-Infused Micronized Cartilage Allograft Augmentation. Arthrosc Tech. 2018; 7(4):e361-e365. PMC: 5982236. DOI: 10.1016/j.eats.2017.10.005. View

3.
Zhao Z, Ma J, Ma X . Different Intra-articular Injections as Therapy for Hip Osteoarthritis: A Systematic Review and Network Meta-analysis. Arthroscopy. 2020; 36(5):1452-1464.e2. DOI: 10.1016/j.arthro.2019.09.043. View

4.
Everhart J, Abouljoud M, Poland S, Flanigan D . Medial compartment defects progress at a more rapid rate than lateral cartilage defects in older adults with minimal to moderate knee osteoarthritis (OA): data from the OA initiative. Knee Surg Sports Traumatol Arthrosc. 2018; 27(8):2401-2409. DOI: 10.1007/s00167-018-5202-1. View

5.
Ding C, Garnero P, Cicuttini F, Scott F, Cooley H, Jones G . Knee cartilage defects: association with early radiographic osteoarthritis, decreased cartilage volume, increased joint surface area and type II collagen breakdown. Osteoarthritis Cartilage. 2005; 13(3):198-205. DOI: 10.1016/j.joca.2004.11.007. View